ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States November 20, 2025 / Press / Mike Zhou ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States Read More »
Indian Society of Anaesthesiologists Hosts Nationwide Launch of Ryanodex® in India November 11, 2025 / Press / Mike Zhou Indian Society of Anaesthesiologists Hosts Nationwide Launch of Ryanodex® in India Read More »
ACA Pharma Named Exclusive Distributor for Feraheme® in Hong Kong, Macau, Greater Bay Area, Mainland China, and Singapore October 23, 2025 / Press / Mike Zhou ACA Pharma Named Exclusive Distributor for Feraheme® in Hong Kong, Macau, Greater Bay Area, Mainland China, and Singapore Read More »
ACA Pharma Named Exclusive Distributor for Ryanodex® and Barhemsys® in Hong Kong, Macau, Singapore, and Greater China October 9, 2025 / Press / Mike Zhou ACA Pharma Named Exclusive Distributor for Ryanodex® and Barhemsys® in Hong Kong, Macau, Singapore, and Greater China Read More »
2025’s Biggest Shift in Orphan Drugs: Months-Not-Years Access to Greater China October 2, 2025 / Overview / Mike Zhou 2025’s Biggest Shift in Orphan Drugs: Months-Not-Years Access to Greater China Read More »
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market September 12, 2025 / Press / Mike Zhou KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market Read More »
Named Patient Program Overview for China July 28, 2025 / Overview / Mike Zhou Named Patient Program Overview for China Read More »
Deflazacort Launch in China via Macau Fast-Track Pathway July 14, 2025 / Case Studies / Mike Zhou Deflazacort Launch in China via Macau Fast-Track Pathway Read More »
